MENU
TCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TScan Therapeutics (TCRX) Ownership - Who owns TScan Therapeutics?
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer... Show more
Profile
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
68.47M
P/E Ratio
N/A
Total Cash
290.11M
Projected Growth
N/A
Total Debt
97.38M
Revenue
2.82M
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash/Share
5.13
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
TCRX
Capitalization
68.5M
P/E Ratio
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash
290M
Total Cash/Share
5.13
Total Debt
97.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
2.82M
ROE
N/A
Book Value
241M
P/B Ratio
0.28
Cash Flow
N/A
Earnings
-1.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
8.14
Current Revenue Per Employee
3410.26
Dividends Per Share - Security
N/A
EBITDA
-119.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.64
Shares Held By Institutions
132M
Shares Outstanding - Current
56.6M
Total Liabilities
130M
Total Volume MTD
N/A
Value
1
Gain YTD
-60.197
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com